Reducing cardiovascular risk in patients with type 2 diabetes mellitus

被引：0
|
作者：
Nicholls, Stephen J. [1 ]
Ryden, Lars [2 ]
机构：
[1] Cleveland Clin, Ctr Cardiovasc Diagnost & Prevent, Dept Cardiovasc Med & Cell Biol, Cleveland, OH 44195 USA
[2] Karolinska Inst, Dept Med, Cardiol Unit, Stockholm, Sweden
来源：
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION | 2010年 / 17卷
关键词：
D O I：
10.1097/01.hjr.0000368716.79219.21
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S1 / S1
页数：1
相关论文
共 50 条
  • [31] Risk factors for cardiovascular autonomic neuropathy in type 2 diabetes mellitus patients
    Semyatichko, E.
    Nemtsova, V.
    Feclina, I.
    JOURNAL OF NEUROLOGY, 2007, 254 : 110 - 110
  • [32] Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus
    Budoff, Matthew J.
    Wilding, John P. H.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (05)
  • [33] Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus
    Cockcroft, JR
    Wilkinson, IB
    Evans, M
    McEwan, P
    Peters, JR
    Davies, S
    Scanlon, MF
    Currie, CJ
    AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (11) : 1463 - 1467
  • [34] Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
    Song, Do Kyeong
    Hong, Young Sun
    Sung, Yeon-Ah
    Lee, Hyejin
    PLOS ONE, 2024, 19 (02):
  • [35] CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS WITH OR WITHOUT METABOLIC SYNDROME
    Millan, J.
    Garcia Calzado, C.
    Recarte, C.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 29 - 29
  • [36] Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus
    Lorber, Daniel
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2014, 7 : 169 - 183
  • [37] Implications of rosiglitazone and pioglitazone on cardiovascular risk in patients with type 2 diabetes mellitus
    Irons, BK
    Greene, RS
    Mazzolini, TA
    Edwards, KL
    Sleeper, RB
    PHARMACOTHERAPY, 2006, 26 (02): : 168 - 181
  • [38] Endocan is Related to Increased Cardiovascular Risk in Type 2 Diabetes Mellitus Patients
    Klisic, Aleksandra
    Kotur-Stevuljevic, Jelena
    Ninic, Ana
    METABOLIC SYNDROME AND RELATED DISORDERS, 2023, 21 (07) : 362 - 369
  • [39] Expression of miRNAs as a marker for cardiovascular risk in patients with type 2 diabetes mellitus
    Gateva, P.
    Mihaleva, I.
    Kamenova, K.
    Giragosyan, S.
    Dodova, R.
    Kaneva, R.
    Dimova, I.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 852 - 853
  • [40] Coronary Calcium Scoring and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus
    Vicente Sanchez, Belkis M.
    Zerquera Trujillo, Gisela
    Jorrin Roman, Felix. R.
    de la Cruz Avilez, Lazaro E.
    Alpizar, Elodia M. Rivas
    MEDISUR-REVISTA DE CIENCIAS MEDICAS DE CIENFUEGOS, 2011, 9 (01): : 73 - 78
12345